View Item 

Show simple item record

ICSH recommendations for assessing automated high‐performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2

dc.contributor.authorStephens, A. D.en_US
dc.contributor.authorColah, R.en_US
dc.contributor.authorFucharoen, S.en_US
dc.contributor.authorHoyer, J.en_US
dc.contributor.authorKeren, D.en_US
dc.contributor.authorMcFarlane, A.en_US
dc.contributor.authorPerrett, D.en_US
dc.contributor.authorWild, B. J.en_US
dc.date.accessioned2015-10-07T20:43:02Z
dc.date.available2016-12-01T14:33:05Zen
dc.date.issued2015-10en_US
dc.identifier.citationStephens, A. D.; Colah, R.; Fucharoen, S.; Hoyer, J.; Keren, D.; McFarlane, A.; Perrett, D.; Wild, B. J. (2015). "ICSH recommendations for assessing automated high‐performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2." International Journal of Laboratory Hematology 37(5): 577-582.en_US
dc.identifier.issn1751-5521en_US
dc.identifier.issn1751-553Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/113742
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Scientificen_US
dc.subject.otherhemoglobin A2en_US
dc.subject.otherHigh‐performance liquid chromatographyen_US
dc.subject.otherβ‐thalassemiaen_US
dc.subject.othercapillary electrophoresisen_US
dc.titleICSH recommendations for assessing automated high‐performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/113742/1/ijlh12413.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/113742/2/ijlh12413_am.pdf
dc.identifier.doi10.1111/ijlh.12413en_US
dc.identifier.sourceInternational Journal of Laboratory Hematologyen_US
dc.identifier.citedreferenceTraeger‐Synodinos J, Harteveld CL, Old JM, Petrou M, Galanello R, Giordano PC, Angastiniotis M, Salle DLB, Henderson S, May A. EQMN Best Practice Guidelines for methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Eur J Hum Genet 2015; 23: 560 – 70.en_US
dc.identifier.citedreferenceInternational Committee For Standardization In Haematology. Recommendations for selected methods for quantitative estimation of Hb A2 and for Hb A2 reference preparation. Br J Haematol 1978; 38: 573 – 8.en_US
dc.identifier.citedreferenceGiordano PC. Editorial: measurement of HbA2. Int J Lab Hematol 2012; 34: 335.en_US
dc.identifier.citedreferenceIvaldi G, Barberio G, Harteveld CL, Giordano PC. HbA2 measurements in β‐thalassemia and other conditions. Thalassemia Rep, 2014; 4: 1832: 45–8.en_US
dc.identifier.citedreferencePaleari R, Gulbis B, Cotton F, Mosca A. Interlaboratory comparison of current high‐performance methods for HbA2. Int J Lab Hematol 2012; 34: 362 – 8.en_US
dc.identifier.citedreferenceBatterbee H, De la Salle B, McTaggart P, Dore C, Wild B, Hyde K. Evaluation of UKNEQAS(H) Hb A2 and related performance data. 2010 cited 1/2/2013; Available from: www.ukneqash.org.en_US
dc.identifier.citedreferenceWeatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th edn. Oxford: Blackwell Scientific, 2001.en_US
dc.identifier.citedreferenceStephens AD, Angastiniotis M, Baysal E, Chan V, Fucharoen S, Giordano PC, Hoyer JD, Mosca A, Wild B. ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol 2012; 34: 1 – 13.en_US
dc.identifier.citedreferenceMeyer VR. Practical High Performance Liquid Chromatography. Chichester, UK: Wiley, 2010.en_US
dc.identifier.citedreferenceCLSI. Protocol for the Evaluation, Validation, and Implementation of Coagulometers. H57‐A. Wayne, PA: Cliniical and laboratory Standards Institute; 2008.en_US
dc.identifier.citedreferenceCLSI. Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures, EP10‐A3. Vol. 26. Wayne, PA: Clinical and Laboratory Standards Insitute; 2006.en_US
dc.identifier.citedreferenceBroughton PMG, Buttolph MA, Gowenlock AH, Neill DW, Skentelbery RG. Recommended scheme for the evaluation of instruments for automatic analysis in the clinical biochemistry laboratory. J Clin Pathol 1969; 22: 278 – 84.en_US
dc.identifier.citedreferenceEuropean Medicines Agency. Guideline on Bioanalytical Method Validation. 2011, European Medicines Agency: EMEA/CHMP/EWP/192217/2009. 1–22.en_US
dc.identifier.citedreferencePharmaceutical Outsource Solutions. Bioanalytical Method Validation Summary. 2001 [July 2013; 1–2]. Available from: www.pharmoutsource.com/publications.en_US
dc.identifier.citedreferenceDolan JW. Peak Tailing and Resolution. LCGC Europe, 2002 (May): 1–4.en_US
dc.identifier.citedreferenceFDA. Guidance for Industry, Bioanalytical Method Validation (being revised, Feb, 2015). 2001; Available from: www.fda.gov/download/drugs/…/guidances/ucm070107.pdfen_US
dc.identifier.citedreferencePaleari R, Munoz A, Mosca A. Towards the development of a certified reference material for hemoglobin A2. Clin Chem Lab Med 2010; 48: 1611 – 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ijlh12413.pdf
Size:
90.66KB
Format:
PDF
View/Open
Name:
ijlh12413_am.pdf
Size:
337.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.